AI Article Synopsis
- This study assesses the effectiveness of cancer drugs approved by the FDA through single-arm clinical trials using a specific evaluation scale.
- The European Society of Medical Oncology Magnitude of Clinical Benefit Scale is utilized to measure the clinical benefits of these drugs.
- The focus is on understanding how these drugs perform when evaluated through non-randomized methods compared to traditional randomized trials.
Article Abstract
This study uses the European Society of Medical Oncology Magnitude of Clinical Benefit Scale to evaluate the clinical benefit of anticancer drugs that gained approval by the US Food and Drug Administration based on single-arm rather than randomized clinical trials.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584270 | PMC |
| http://dx.doi.org/10.1001/jamaoncol.2018.4300 | DOI Listing |
Publication Analysis
Top Keywords
clinical benefit
12
magnitude clinical
8
food drug
8
drug administration
8
administration based
8
based single-arm
8
benefit cancer
4
cancer drugs
4
drugs approved
4
approved food
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!